Chondroitin-Akos ointment 5% 30g tuba

Description

Composition
Active substance:
100 g of ointment contains: sodium chondroitin sulfate (in terms of dry matter) – 5.0 g ;.
Excipients:
Dimethylsulfoxide (dimexide) – 10.0 g, lanolin (lanolin anhydrous) – 15.0 g Vaseline (Vaseline medical) – 50.0 g Purified water – 100.0 g
Product form:
Ointment for external use 5%. 30, 50 g aluminum tubes with screwed Bouchon polymer or polymer laminate with screwed Bouchon. 1 tube with instructions for use placed in a pile of cardboard.
Contraindications
Hypersensitivity, the integrity of the skin in places intended application.
Dosage
5 %
Indications
Degenerative-dystrophic diseases of joints and spine – Osteoarthritis, mainly affecting the large joints, intervertebral osteochondrosis.
Interaction with other drugs
Not established cases adverse drug interactions when appointing ointment therapy with other drugs included in the conventional scheme of treating degenerative diseases of joints and spine.
Overdose
When applied topically Chondroitin-Akos ointments unlikely overdose (due to lack of systemic absorption of the drug). To date, cases of overdose Ointment Chondroitin-ICCO has not been reported.
pharmachologic effect
Pharmacological group:
Tissue repair promoter.
Pharmacodynamics:
The high molecular weight mucopolysaccharide, which slows down bone resorption and reduces the loss of calcium. Improves calcium and phosphorus metabolism in the cartilage tissue, accelerates its recovery, hinders the process of degeneration of cartilage and connective tissue. Inhibits enzymes that cause cartilage damage, stimulates the synthesis of glycosaminoglycans, contributes to the regeneration of the joint capsule and cartilage surfaces of the joints, increases the production of synovial fluid. Because of its structural similarity to heparin, prevents the formation of fibrin clots in synovial and subchondral microcirculatory bed. It reduces pain and increases mobility of the affected joints. Slows the progression of osteoarthritis. Dimethylsulfoxide, which is part of ointments, anti-inflammatory, analgesic and fibrinolytic action, contributes to a better penetration of chondroitin sulfate across cell membranes.
Pharmacokinetics:
It has virtually no systemic absorption.
Pregnancy and breast-feeding
Pregnancy and lactation (lactation) Ointment Chondroitin-ICCO is appointed only after consulting a doctor and with care, the duration of treatment determined by the doctor.
Conditions of supply of pharmacies
Without recipe.
side effects
In rare cases, possible allergic reactions, the drug is overturned. If you notice any other side effects not mentioned in the instructions, tell your doctor.
special instructions
Avoid ointments contact with mucous membranes and open wounds. Do not use the drug without consulting a doctor at the age of 18 years.
Storage conditions
In the dark place at a temperature of from 2 ° C to 20 ° C. Keep out of the reach of children.
Dosing and Administration
Outdoor! Ointment Chondroitin-ICCO applied 2-3 times a day to the skin lesions over the fire and rub for 2-3 minutes until completely absorbed. Course of treatment 2-3 weeks.
If necessary, repeat the treatment. In severe cases simultaneously administered chondroitin sulfate formulations for ingestion or for intramuscular injection.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist